Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_assertion type Assertion NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_head.
- NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_assertion description "[In particular, these include significantly reduced expression levels of three matrix metallopeptidases (MMP1, MMP3, MMP16), follistatin, and STAT1, and significantly increased expression levels of fibroblast growth factors (FGF9, FGF11), a number of collagen genes and other ECM genes in DD patient samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_provenance.
- NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_assertion evidence source_evidence_literature NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_provenance.
- NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_assertion SIO_000772 23554969 NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_provenance.
- NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_assertion wasDerivedFrom befree-2016 NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_provenance.
- NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_assertion wasGeneratedBy ECO_0000203 NP1066199.RAdvaa1psPIaUP6ZHUhBhSGgrg4XdRpBq8ZayN3ZuVtAU130_provenance.